{"schema_version":"secwatch.filing_event.v1","accession":"0001664710-25-000078","form_type":"8-K","ticker":"KROS","cik":"0001664710","company_name":"Keros Therapeutics, Inc.","filed_at":"2025-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.591913+00:00","generated_at":"2026-05-17T09:28:54.309689+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Keros CEO to present at Wells Fargo and H.C. Wainwright conferences","bullets":["CEO Jasbir Seehra will participate in a fireside chat at Wells Fargo Healthcare Conference on Sept 4 at 2:15 p.m. ET.","He will also present at H.C. Wainwright 27th Annual Global Investment Conference on Sept 9 at 12:00 p.m. ET.","Archived replays will be available on Keros website for up to 90 days after each event."],"urls":{"canonical":"https://secwatch.observer/filing/0001664710-25-000078","json":"https://secwatch.observer/filing/0001664710-25-000078.json","markdown":"https://secwatch.observer/filing/0001664710-25-000078.md","text":"https://secwatch.observer/filing/0001664710-25-000078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1664710/000166471025000078/0001664710-25-000078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1664710/000166471025000078/kros-20250828.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:28:54.309689+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}